# RINVOQ
> **NDA211675** · New Drug Application · Sponsor: ABBVIE · Approved 2019-08-16
## Drug
- **FDA Application Number:** NDA211675
- **Application type:** New Drug Application
- **Brand name:** RINVOQ
- **Generic name:** UPADACITINIB
- **Active ingredients:** UPADACITINIB
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2019-08-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211675)
---
*AI Analytics · CC0 1.0*